Waa maxay Ikhtiyaarada Gudbinta Unugyada Stem ee Bukaanka Qaba Kansarka Dhiiga

GUURKA dhuuxa lafta

Macluumaadka soo socdaa waa koob guud mana aha mid loo dhan yahay. Bukaan kastaa wuxuu leeyahay duruufo gaar ah, markaa bukaanadu waa inay kala hadlaan dhammaan daawaynta habboon dhakhaatiirtooda.

Table of Contents

  • Go'aanka ah in lagu tallaalo qof weyn oo DHAMMAAN qaba waxay ku xiran tahay sifooyinka leukemia-ga, caafimaadka guud ee bukaanka iyo da'da bukaanka. 
  • Ku-tallaalidda unugyada asliga ah ee allogeneic waxay noqon kartaa ikhtiyaarka bukaannada khatarta sare leh DHAMMAAN kuwaas oo cudurkoodu ku jiro cafiska markii ugu horreysay ama cudurkoodu uu ku jiro qayb ka mid ah cafiska (waa haddii ku-deeqaha ku habboon la heli karo).
  • Doorashada u dhaxaysa ku-tallaalidda allogeneic-ka iyo daaweynta kiimoterabiga oo sii socota aad ayey ugu caddaatay bukaannada leh heerka-khatarta DHAMMAAN oo cudurkoodu ku jiro cafiska koowaad. Bukaannadani waa inay kala hadlaan heerka tallaalka unugyada caadiga ah iyo/ama la dhimay ee unugga unugyada tarma ee allogeneic-ku-tallaalidda dhakhaatiirtooda si ay u go'aamiyaan haddii mid ka mid ah noocyada tallaalka lagu taliyey iyaga. Qadarka ugu yar ee cudurrada haraaga ah ayaa laga yaabaa inay saameyn ku yeeshaan go'aanka in la sii wado tallaalka iyo in kale.
  • Ku-tallaalidda unugyada asliga ah ee ka baxsan goobta tijaabada bukaan-socodka laguma talinayo daawaynta DHAMMAAN.
  • Inta badan carruurta leh DHAMMAAN (qiyaastii 75 ilaa 80 boqolkiiba) uma baahna tallaalka unugga asliga ah. Ilmaha qaba cudurka refractory ama soo noqday DHAMMAAN waxa laga yaabaa in loo tixgeliyo ku-tallaalidda allogeneic
  • Khatarta wanaagsan ee AML: Unugyada stem-ka-tallaalidda guud ahaan laguma talinayo marka ugu horreysa ee la cafiyo. 
  • Khatarta Dhex-dhexaadka ah AML: Bukaanka leh khatarta dhexe ee AML waa in ay kala hadlaan heerka caadiga ah iyo/ama xoojinta unugyada unugyada allogeneic ku-tallaalidda takhtarkooda si loo go'aamiyo haddii mid ka mid ah tallaaladan lagu taliyey iyaga.
  • Khatarta Sare ee AML: Allogeneic stem cell transplantation waxaa guud ahaan lagula taliyaa cafiska koowaad ama qayb ka mid ah cafiska bukaanada u sharaxan xubinta taranka oo leh deeq bixiye allogeneic ku haboon. Ku-tallaalidda unugyada tarma ee allogeneic-ka-yar ayaa lagu talin karaa bukaannada da'da weyn ama bukaannada qaba cudurrada qaarkood. 
  • Ku-tallaalidda unugyada asliga ah ee ka baxsan goobta-tijaabada bukaan-socodka caadi ahaan looma isticmaalo in lagu daweeyo AML
  • Allogeneic transplantation (badanaa la dhimay-xoogga laakiin mararka qaarkood heerka) ayaa lagu hayaa daraasad lagu sameeyay tijaabooyinka kiliinikada sida daawaynta bukaanada qaba CLL kuwaas oo leh astaamo halis sare leh ama cudur soo noqday ka dib daawaynta caadiga ah

Myeloid leukemia (CML) daba-dheeraada

  • Kiisaska cudurro horumarsan ama dib-u-celin ah ama dulqaad la'aanta daawaynta afka ee CML, beddelka unugyada unugyada caadiga ah ee allogeneic (ama la dhimay/xoogga tallaalka unugyada unugyada unugyada) ayaa lagu talin karaa bukaannada haysta ku-deeqaha allogeneic ku habboon oo la heli karo.
  • Ku-tallaalidda unugyada asliga ah ayaa loo isticmaalaa in lagu daweeyo bukaannada HL kuwaas oo cudurkoodu soo noqdo ka dib daaweynta bilowga ah. 
  • Halbeegga iyo xoojinta-xoogga allogeneic-ka-tallaalidda unugyada tarma ayaa lagu hayaa daraasadda tijaabooyinka bukaan-socodka sida daaweynta bukaannada HL ee leh ku-deeqaha allogeneic ku habboon.
  • Ku-tallaalidda unugyada asliga ah ee iswada leh ayaa guud ahaan loo isticmaalaa in lagu daweeyo bukaannada soo noqday ama cudurka dib u laabashada; ku-tallaalidda inta lagu jiro cafiska koowaad waxaa lagu sameeyaa oo keliya tijaabooyinka bukaan-socodka, marka laga reebo noocyada NHL, oo ​​ay ku jiraan xaaladaha qaarkood ee lymphoma unugga mantle iyo T-cell lymphoma. 
  • Allogeneic transplantation waxaa loo isticmaalaa in lagu daweeyo bukaanada la doortay ee qaba NHL.
  • Bukaan-socodka waa in ay hubiyaan dhakhaatiirtooda oo ay ogaadaan haddii ay jiraan talooyin gaar ah oo loogu talagalay nooca-hoosaadka NHL.
  • Beddelka unugyada tarma ee caadiga ah ee allogeneic (ama beddelka unugyada tarma ee allogeneic-ka-yar ee loogu talagalay bukaannada da'da weyn ama kuwa kale ee la doortay) ayaa laga yaabaa in lagula taliyo dadka qaba dhexdhexaad-ama khatar sare MDS iyo ku-deeqaha allogeneic ku habboon oo la heli karo.
  • Ku-tallaalidda unugyada asliga ah waa qayb muhiim ah oo ka mid ah daaweynta bukaannada myeloma qaarkood. 
  • Ku-tallaalidda unugyada asliga ah caadi ahaan looma isticmaalo bukaannada myeloma laakiin waxay noqon kartaa ikhtiyaar daawayn oo loogu talagalay bukaannada da'da yar ee la doortay kuwaas oo haysta ku-deeqaha allogeneic ku habboon oo la heli karo. 
  • Ku-tallaalidda unugyada tarma ee allogeneic-ka-dhimista ayaa loo adeegsadaa xaaladaha qaarkood ka dib wareejinta unugyada tarma ee iswada ee bukaannada haysta ku-deeqaha allogeneic ku habboon oo la heli karo.

Myeloproliferative neoplasms (MPNs)

  • Myelofibrosis: Beddelka unugyada tarma ee caadiga ah ee allogeneic (ama beddelka unugyada tarma ee allogeneic-ka-yar ee loogu talagalay bukaannada da'da weyn ama bukaannada qaba cudurrada qaarkood) ayaa laga yaabaa in lagula taliyo bukaannada haysta ku-deeqaha allogeneic ku habboon oo la heli karo.
  • Polycythemia vera (PV) iyo thrombocythemia lagama maarmaanka ah (ET): Allogeneic-ka-tallaalidda unugyada asliga ah iyo ka-tallaalidda unugyada tarma ee allogeneic ee hoos u dhaca ayaa mararka qaarkood loo isticmaalaa in lagu daweeyo cudurradan.